Case Reports in Ophthalmological Medicine · 2011 · 12 citations · 3 references
MedicineOncologyOphthalmologyNeoplasiaOcular DiseaseOcular OncologyChoroidal TumorsIntraocular TumorsMelanocytic LesionsMelanocytic TumorsOcular TumorsUveal MelanomaFluorescein Angiography FindingsFundus Fluorescein AngiographyPigmented Ocular LesionsUveal Melanocytic LesionsUveal Melanoma MetastasisUveal NeoplasiaUveal NevusUveal Tumors
Purpose. To describe a patient with Bilateral Diffuse Uveal Proliferation who presented initially with a clinical picture consistent with choroidal melanoma. Methods. Presentation of a clinical case with fundus photos, fluorescein angiography, and optical coherence tomography. Results. A 70-year-old Caucasian male with history of esophageal cancer presented with an asymptomatic pigmented choroidal lesion in his left eye initially diagnosed as choroidal nevus. This lesion enlarged over the course of a year and developed orange pigment and increased thickness. A metastatic workup was negative, and a radioactive iodine plaque was placed on the left eye. Over the next six months, the visual acuity in his left eye decreased. His clinical picture was consistent with unilateral Diffuse Uveal Proliferation. A recurrence of his esophageal carcinoma with metastasis was discovered and palliative chemotherapy was initiated. Although his visual acuity improved in the left eye, similar pigmentary changes developed in the right fundus. His visual acuity in both eyes gradually decreased to 20/200 until his death a year later. Conclusion. BDUMP should always be considered in the differential diagnosis of patients with pigmented fundus lesions and a history of nonocular tumors.
3
Early Lesions of Bilateral Diffuse Melanocytic Proliferation
Anita Leys · Archives of Ophthalmology · 1991 · 40 citations
Medicine, Oncology, Ophthalmology +17
Cancer-associated Nummular Loss of the Pigment Epithelium
Simon Wu, Jason S. Slakter, Jerry A. Shields et al. · American Journal of Ophthalmology · 2005 · 34 citations
Medicine, Dermatology, Oncology +14